In type 2 diabetes, some glucose-lowering drugs reduce HbA1c more than others; drugs do not differ for mortality

Annals of Internal Medicine
Gunjan Y Gandhi

Abstract

Tsapas A, Avgerinos I, Karagiannis T, et al. Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis. Ann Intern Med. 2020;173:278-86. 32598218.

Methods Mentioned

BETA
amputations

Software Mentioned

CINeMA ( Confidence In Network Meta - Analysis )
CINeMA
Cochrane Risk of Bias

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.